foocen Inhibitors
Foocen inhibitors are a distinct class of chemical compounds characterized by their ability to specifically target and modulate the activity of the enzyme foocen. These inhibitors typically function by binding to the active site of the enzyme or by interacting with regulatory regions that influence its catalytic efficiency. The structure of foocen inhibitors often includes a core scaffold designed to fit precisely within the enzyme's binding pocket, facilitating a high degree of specificity and affinity. These inhibitors can be either competitive or non-competitive, depending on their mode of action, and their effectiveness is frequently determined by the molecular features that allow for strong interactions with foocen's key amino acid residues. Researchers often focus on the optimization of these molecular interactions, ensuring that the inhibitors maintain structural stability and are resistant to rapid degradation.
The chemical design of foocen inhibitors varies widely, with some being small molecules while others possess larger, more complex frameworks that interact with multiple sites on the enzyme. The functional groups on these molecules are critical in determining their solubility, bioavailability, and interaction profiles. Foocen inhibitors may undergo further modification to improve their binding affinity or to fine-tune their inhibition kinetics. Analytical methods such as crystallography, molecular docking studies, and kinetic assays are frequently employed to understand the precise binding mechanisms and to design more effective inhibitors. The ongoing refinement of these inhibitors contributes to the growing understanding of enzyme regulation at a molecular level.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic acid could downregulate foocen by inhibiting histone deacetylase, leading to hyperacetylation of histones and potentially repressing transcription of the foocen gene. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
This compound may decrease foocen expression through histone deacetylase inhibition, which can cause alterations in chromatin structure, leading to transcriptional repression of the foocen gene. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine may reduce foocen expression by causing DNA demethylation, which could activate transcriptional repressors or silence activating elements of the foocen gene. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid could inhibit foocen expression by binding to retinoic acid receptors that interact with promoter regions of the foocen gene, leading to repression of its transcription. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin may lead to a decrease in foocen protein levels by inhibiting the mTOR pathway, which is responsible for protein synthesis, including that of foocen. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D may inhibit transcription of the foocen gene by intercalating DNA and preventing the advancement of RNA polymerase along the DNA template. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide could decrease levels of foocen by halting the translocation step in protein synthesis, thus preventing the elongation of the foocen polypeptide chain. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059 may inhibit the expression of foocen by blocking MEK activity, which is part of the MAPK/ERK pathway, a pathway that can control the transcription of various genes, including foocen. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY 294002 may lead to a reduction in foocen expression by inhibiting PI3K, which is involved in the PI3K/Akt signaling pathway, a pathway that can control various cellular processes including gene expression. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
As an inhibitor of JNK, SP600125 could reduce the expression of foocen by preventing the activation of transcription factors that are regulated by the JNK signaling pathway. | ||||||